Walleye Trading’s 10x Genomics TXG Stock Holding History

Walleye Trading’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-900	Closed	-$33.8K	–	4926
2024 Q1	$33.8K	Sell	900 -14,100	-94%	-$619K	﹤0.01%	4120
2023 Q4	$839K	Sell	15,000 -32,400	-68%	-$1.41M	﹤0.01%	2632
2023 Q3	$1.96M	Buy	47,400 +12,700	+37%	+$661K	0.01%	1797
2023 Q2	$1.94M	Buy	34,700 +26,400	+318%	+$1.43M	0.01%	1671
2023 Q1	$463K	Buy	8,300 +2,200	+36%	+$103K	﹤0.01%	2868
2022 Q4	$222K	Buy	+6,100	New	+$199K	﹤0.01%	3487
2022 Q2	–	Sell	-4,000	Closed	-$304K	–	5680
2022 Q1	$304K	Buy	+4,000	New	+$350K	﹤0.01%	3434
2021 Q3	–	Sell	-400	Closed	-$78K	–	5742
2021 Q2	$78K	Buy	400 +300	+300%	+$54.3K	﹤0.01%	4476
2021 Q1	$18K	Sell	100 -1,000	-91%	-$173K	﹤0.01%	4569
2020 Q4	$156K	Sell	1,100 -300	-21%	-$43.5K	﹤0.01%	3685
2020 Q3	$175K	Buy	+1,400	New	+$147K	﹤0.01%	3088

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Walleye Trading's TXG Position: Q4 2023 in Review

Walleye Trading sold out of 10x Genomics (TXG) in Q4 2023, closing a stake of 36,868 shares — an estimated $1.6M sold.

Walleye Trading first reported a position in TXG in Q3 2020 and held it in 7 quarters. The position peaked at $1.52M in Q3 2023. 275 funds tracked by Wall St. Rank hold TXG as of Q4 2023.

Walleye Trading reported no remaining 10x Genomics position as of Q4 2023 after selling out during the quarter.
Walleye Trading sold 36,868 10x Genomics shares in Q4 2023, an estimated $1.6M.
Walleye Trading first reported a position in 10x Genomics in Q3 2020 and held it in 7 quarters.
Walleye Trading's 10x Genomics position peaked at $1.52M in Q3 2023.
275 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2023.

Based on Walleye Trading's 13F filing for Q4 2023, filed 14 Feb 2024.